We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

48 hedge funds and large institutions have $18.1M invested in Precision BioSciences in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more capital invested

Capital invested by funds: $14.7M → $18.1M (+$3.35M)

13% less funds holding

Funds holding: 55 → 48 (-7)

14.45% less ownership

Funds ownership: 50.58% → 36.13% (-14%)

18% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 11

50% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 12

Holders
48
Holders Change
-7
Holders Change %
-12.73%
% of All Funds
0.64%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
9
Reduced
11
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BFM
Boothbay Fund Management
New York
+$1.02M
2
ACM
Aquilo Capital Management
California
+$966K
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$965K
4
Millennium Management
Millennium Management
New York
+$334K
5
TC
Tejara Capital
United Kingdom
+$200K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$1.15M
2
Citadel Advisors
Citadel Advisors
Florida
-$586K
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$381K
4
MSAM
Moloney Securities Asset Management
Missouri
-$229K
5
Squarepoint
Squarepoint
New York
-$179K
Name Holding Trade Value Shares
Change 		Change in
Stake
VC
26
Vivo Capital
California
$22.3K – – –
NFSG
27
Newbridge Financial Services Group
Florida
$7.63K – – –
TRCT
28
Tower Research Capital (TRC)
New York
$7.16K -$14.3K -2,808 -65%
Carson Wealth (CWM LLC)
29
Carson Wealth (CWM LLC)
Nebraska
$5K – – –
SS
30
SBI Securities
Japan
$2.24K +$127 +25 +6%
Barclays
31
Barclays
United Kingdom
$1.83K -$12.7K -2,486 -87%
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$1.31K – – –
Bank of America
33
Bank of America
North Carolina
$630 -$144K -28,346 -100%
Fidelity Investments
34
Fidelity Investments
Massachusetts
$477 -$3.05K -600 -86%
SC
35
SouthState Corp
Florida
$453 – – –
Zurich Cantonal Bank
36
Zurich Cantonal Bank
Switzerland
$329 – – –
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$262 -$494 -97 -64%
Wells Fargo
38
Wells Fargo
California
$167 – – –
AWM
39
Ameliora Wealth Management
Switzerland
$157 – – –
NA
40
NewEdge Advisors
Louisiana
$103 – – –
FDCDDQ
41
Federation des caisses Desjardins du Quebec
Quebec, Canada
$57 – – –
IRC
42
Investors Research Corp
Georgia
$38 – – –
JP Morgan Chase
43
JP Morgan Chase
New York
$38 – – –
MCM
44
MAI Capital Management
Ohio
$34 – – –
FFA
45
Farther Finance Advisors
California
$18 – – –
LWMI
46
Legacy Wealth Management (Idaho)
Idaho
$15 – – –
HI
47
Harbour Investments
Wisconsin
$14 – – –
Goldman Sachs
48
Goldman Sachs
New York
– -$1.15M -302,168 Closed
Citadel Advisors
49
Citadel Advisors
Florida
– -$586K -153,675 Closed
Alyeska Investment Group
50
Alyeska Investment Group
Illinois
– -$381K -100,000 Closed
1
2
3

DTIL Hedge Fund Activity: Q1 2025 in Review

48 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q1 2025, worth a combined $18.1M — up 23% from $14.7M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of DTIL and 6 opened new positions — a net loss of 6 holders — while 11 trimmed existing stakes and 9 added.

The largest buyer was Boothbay Fund Management, opening a new position worth an estimated $1.02M. The largest seller was Goldman Sachs, exiting entirely with an estimated $1.15M sold.

  • 48 institutional investors held Precision BioSciences (DTIL) as of Q1 2025, down from 55 in Q4 2024.
  • Funds reported $18.1M of Precision BioSciences stock for Q1 2025, up 23% quarter-over-quarter.
  • 6 funds opened new Precision BioSciences positions in Q1 2025 and 12 closed out, a net change of -6 holders.
  • The largest Precision BioSciences buyer in Q1 2025 was Boothbay Fund Management, an estimated $1.02M added.
  • The largest Precision BioSciences seller in Q1 2025 was Goldman Sachs, an estimated $1.15M sold.

Based on aggregated 13F filings for Q1 2025.